When a vial of research compound arrives at a laboratory, two questions must be answered before that material can be used with confidence.
The first: how much of what is in the vial is actually the intended compound?
The second: is the dominant compound actually what the label says it is?
These questions sound similar but require entirely different methods to answer. HPLC answers the first. LC-MS answers the second. A research peptide supported by both is fully documented. One supported by only one of them leaves half the picture unverified.
This guide explains how each method works, what it measures, where its limits are, and how their results appear together on a Certificate of Analysis. For a full walkthrough of how to read that COA document, see the peptide COA reading guide in the Bluum research library.
What Peptide Purity Actually Measures
Purity, in the context of a research peptide, is the proportion of the total sample that consists of the target compound relative to everything else present. That everything else is called impurities.
Why impurities form
Impurities in synthetic peptides are not random contaminants. They are predictable byproducts of the synthesis process itself.
When a peptide is manufactured through solid-phase peptide synthesis, an amino acid chain is built one residue at a time. At any point in that chain, a coupling reaction can fail to complete, a protecting group can resist removal, or a side reaction can alter a residue's chemistry. Each of these events produces a molecular species that is chemically related to the target peptide but is not the target peptide. Those species end up in the final product and are measured as impurities.
What the purity percentage represents
For research grade peptide quality, the accepted minimum standard is 98% purity. At that level, at least 98 parts in every 100 of the UV-absorbing material in the sample are the target compound.
The remaining 2% or less consists of synthesis-related species. Below that threshold, the proportion of uncharacterized material is high enough to introduce meaningful uncertainty into quantitative research applications.
Purity is measured primarily through HPLC, while molecular identity is confirmed through mass spectrometry. Both are typically presented together on a Certificate of Analysis. The COAs page at Bluum Peptides shows the format used for every active product batch.
The Five Main Types of Peptide Synthesis Impurities
Before looking at how testing methods detect impurities, it helps to know what categories of impurities are actually present in synthetic research peptides. Most fall into five types.
Truncated and deletion sequences
These are the most common impurity type. They occur when a coupling step fails to add the correct amino acid, or when the growing chain is capped prematurely.
The result is a shorter peptide fragment that shares structural similarity with the target compound but is missing one or more residues. Because they are closely related to the target, these fragments can appear at retention times near the main peak on an HPLC chromatogram.
Oxidation products
Oxidation products form when amino acids with reactive side chains react with atmospheric oxygen during synthesis or storage. Methionine, cysteine, and tryptophan are the residues most susceptible to this.
The oxidized form of the residue alters the compound's molecular mass. This mass shift is detectable through mass spectrometry, which is one reason LC-MS adds information that HPLC alone cannot provide.
TFA and acetate counterion residuals
Trifluoroacetic acid is used to cleave the finished peptide from the synthesis resin and also appears in the HPLC mobile phase during purification. Residual TFA remains in the final lyophilized product as a salt counterion.
Critically, TFA does not absorb UV light at standard detection wavelengths. It does not appear as a peak in an HPLC chromatogram. This means TFA residuals contribute to the gross weight of the vial without registering in the purity percentage. This is one reason HPLC purity and net peptide content are different numbers.
Racemization products
Racemization occurs when the stereospecificity of an amino acid is lost during coupling. The result is a D-amino acid residue in a sequence that should contain only L-amino acids.
Standard HPLC cannot distinguish between enantiomers. Detecting racemization requires chiral-specific analytical methods that go beyond what most routine COA testing includes.
Residual synthesis solvents
Solvents used during solid-phase synthesis, including dimethylformamide and acetonitrile, can persist in trace amounts in the final lyophilized product. These are typically addressed in more comprehensive analytical panels but are not always included on standard research-grade COAs.
How HPLC Measures Peptide Purity
High-performance liquid chromatography is the primary method used for peptide purity testing across the research compound industry. It separates the components of a sample and measures each one as it exits the column.
The reverse-phase separation mechanism
For research peptides, reverse-phase HPLC is the standard approach. The stationary phase inside the column consists of hydrophobic C18 chains. The mobile phase is a polar aqueous solvent, typically water with a gradient of acetonitrile.
As the sample moves through the column, compounds with greater hydrophobicity interact more strongly with the C18 stationary phase and take longer to elute. Compounds with lower hydrophobicity pass through more quickly. This difference in retention time physically separates the target peptide from its related impurities before detection.
How the purity percentage is calculated
A detector at the end of the column operates at a wavelength of 214 to 220 nanometers. At 214 nm, the peptide bond absorbs ultraviolet light. This means the detector registers essentially all peptide-containing species in the sample, regardless of side chain composition.
The output is a chromatogram: a graph showing detector signals over time, with each compound appearing as a distinct peak.
Purity is calculated by dividing the area under the target peak by the total area of all detected peaks, expressed as a percentage. This is the area percentage method and is the figure reported on a COA as HPLC purity.
How to read an HPLC chromatogram
In a well-purified research compound, the chromatogram shows one dominant peak representing the target peptide, with small satellite peaks on either side representing minor impurities.
A clean chromatogram has a single tall, sharp, symmetrical dominant peak with a flat baseline between it and the minor peaks. A broad or asymmetric dominant peak, or multiple peaks of similar height, indicates a less pure sample.
One point to note: the area percentage calculation covers only UV-absorbing organic species. Water, salt counterions, and residual non-chromophore solvents do not appear as peaks and are not factored into the purity result. This is why the HPLC purity figure and the net peptide content of a vial are different numbers.
What HPLC cannot tell you
HPLC purity is a relative measurement. It reports how much of the UV-absorbing material is the dominant peak. It does not identify what that dominant peak is.
A sample could show 99% purity by HPLC and still contain the wrong compound if a labeling error, contamination event, or synthesis failure produced a different peptide with a similar retention time. This is the analytical gap that mass spectrometry fills.
How LC-MS Confirms Peptide Identity
Liquid chromatography mass spectrometry combines the separation power of HPLC with the molecular identification capability of mass spectrometry in a single analytical run. After the column separates the sample components, they pass directly into a mass spectrometer rather than a UV detector. This allows purity profiling and identity confirmation to occur simultaneously.
How mass spectrometry measures molecular weight
Mass spectrometry measures the mass-to-charge ratio of ionized molecules. The instrument records these values and calculates the molecular weight of the compound from the distribution of charge states observed.
That calculated molecular weight is then compared against the theoretical molecular weight derived from the peptide's known amino acid sequence. A match within approximately 2 Daltons confirms the compound is what it claims to be.
ESI mass spectrometry of peptides
The ionization method used in most third party peptide testing lab workflows is electrospray ionization, or ESI. In ESI mass spectrometry of peptides, the liquid sample is sprayed through a charged needle, producing a fine mist of charged droplets.
As the solvent evaporates, the peptide molecules become multiply charged ions that enter the mass spectrometer for analysis. Because the peptide carries multiple charges, a series of peaks appears in the spectrum, each corresponding to a different charge state of the same molecule. The molecular weight is calculated from this distribution.
ESI interfaces directly with the liquid chromatography system, which is why it is the standard method for routine LC-MS COA documentation in research compound testing.
MALDI-TOF peptide analysis
MALDI-TOF uses a different approach. The sample is mixed with a matrix compound on a metal plate and ionized by a laser pulse. MALDI-TOF tends to produce predominantly singly charged ions, which makes spectra easier to interpret visually.
It is faster than ESI-based LC-MS and can tolerate less pure samples, making it practical for rapid identity screening. However, it is not run in-line with HPLC separation. This means MALDI-TOF provides identity data only, without the simultaneous purity profiling that LC-MS delivers.
For comprehensive batch COA documentation, LC-MS is the more complete method because it combines both data points in one run.
When LC-MS results signal a problem
A discrepancy larger than 2 Daltons between the observed and theoretical molecular weight is a meaningful red flag. Possible causes include a sequence error during synthesis, an unintended modification on a reactive residue, or a compound misidentification at the sourcing level.
Any of these would be invisible to HPLC analysis alone, which reinforces why mass spectrometry identity confirmation is a documentation requirement rather than an optional upgrade.
HPLC vs LC-MS: What Each Method Actually Answers
The two methods are complementary, not interchangeable. Each answers a different question about the same compound.
The core distinction
HPLC answers: what percentage of the sample is the dominant compound?
LC-MS answers: what compound is the dominant peak?
A COA built on HPLC data only confirms relative purity but leaves identity unverified. A COA built on mass spectrometry only confirms identity but does not quantify what proportion of the sample is the identified compound.
Why both are required
Together, the two methods answer both questions and produce a documentation standard appropriate for research grade peptide quality purposes. This is why reputable third party testing labs report both methods on every COA, and why a COA that includes only one of the two should be treated as incomplete.
This combined testing approach is what Bluum requires for every batch. Results from both methods are published on the COA lookup page alongside the batch number and date of analysis for every active product.
Research Peptide Purity Standards: What the Grades Mean
Purity grades in research compound documentation are not arbitrary marketing tiers. They reflect the actual proportion of non-target material in a sample.
Crude grade (below 70%)
Material at this grade has undergone minimal purification following synthesis. It contains a high proportion of synthesis byproducts and is appropriate only for very early exploratory work where compound identity is being established and precise quantitation is not yet required.
Standard grade (70 to 90%)
This represents material purified through a single pass. It still contains a meaningful fraction of related impurities and is rarely appropriate for controlled research applications that require consistent analytical behavior across experiments.
Research grade (95 to 98%)
This is the working standard for most laboratory research with synthetic peptides. The proportion of uncharacterized material is low enough for most assay formats. The exact impact on any specific experiment depends on the assay's sensitivity requirements.
High purity (98% and above)
This is the standard applied to the entire Bluum Peptides research catalog. At this level, the sample is dominated by the target compound with minimal synthesis byproducts.
The majority of Bluum products test at 99% or above by HPLC, with full LC-MS identity confirmation included in every batch COA.
How Purity Data Appears on a COA
Understanding the test methods makes reading a COA significantly more straightforward.
Reading the HPLC section
The purity section of a COA should show the HPLC result as an area percentage. It is typically labeled as "Purity by HPLC" or "Area% by RP-HPLC." Method details including column type, mobile phase, and detection wavelength should appear alongside the result.
Without method details, the purity figure cannot be independently evaluated or reproduced. A result presented only as a number, without the conditions under which it was generated, provides limited analytical confidence.
Reading the mass spectrometry section
The identity section should show both the theoretical molecular weight calculated from the peptide sequence and the observed molecular weight from the mass spectrometry run.
Both figures must be present so the match can be verified directly. A result listed only as "Conforms" without showing the actual observed mass provides less transparency than one that shows the numerical comparison.
For a complete walkthrough of every section of a COA, including batch number, testing date, and lab identification fields, the peptide COA reading guide covers the full document structure in detail.
How Bluum Peptides Tests Every Batch
Every product in the Bluum Peptides research catalog is tested by Janoshik Analytical or BioRegen before it is made available. Both are independent third-party laboratories with no commercial relationship to Bluum beyond their contracted analytical role.
What each COA includes
Each COA produced through this process contains the following:
- HPLC purity expressed as area percentage
- LC-MS identity confirmation with both theoretical and observed molecular weights
- Batch or lot number tied to the specific production run
- Date of analysis
- Testing laboratory name and identifying information
Purity and update standards
All products are verified at 98% purity or above before release. The majority of batches test at 99% or higher. COAs are updated when new batches are introduced and are accessible by product or batch number through the COA lookup page.
Frequently Asked Questions
What is HPLC purity in research peptides?
HPLC purity is the area percentage of the target compound's chromatographic peak relative to the total area of all detected peaks in the sample. It is measured by reverse-phase high-performance liquid chromatography and represents the proportion of UV-absorbing material in the vial that is the intended compound. For research grade peptide quality, 98% or above is the accepted standard.
What does LC-MS confirm that HPLC cannot?
LC-MS confirms the molecular identity of the compound by measuring its molecular weight through mass spectrometry. HPLC measures relative purity but cannot confirm what the dominant compound is. A sample can appear highly pure by HPLC while still being a misidentified compound. LC-MS closes this gap by verifying that the dominant peak matches the expected molecular mass of the target peptide.
What is the difference between ESI and MALDI-TOF in peptide testing?
ESI is the ionization method used in most LC-MS workflows. It interfaces directly with the liquid chromatography system and delivers simultaneous purity and identity data. MALDI-TOF uses laser-based ionization and is faster for standalone identity screening but is not run in-line with HPLC. For comprehensive batch COA documentation, ESI-based LC-MS is the more complete method.
What are the most common impurities in synthetic research peptides?
The five main categories are truncated and deletion sequences, oxidation products from reactive residues, TFA and acetate counterion residuals, racemization products, and residual synthesis solvents. Most are detectable through HPLC and LC-MS, though racemization requires specialized chiral analysis not included in standard COA testing.
Why do research peptides need both HPLC and mass spectrometry testing?
Because the two methods answer different questions. HPLC quantifies how much of the sample is the target compound. Mass spectrometry confirms what that compound is. Without both, a COA either leaves purity unquantified or identity unverified. A complete analytical record for a research-grade compound requires both, which is the standard applied by reputable third-party testing laboratories.
Research Use Only Disclaimer
All compounds available through Bluum Peptides are supplied strictly for laboratory and in vitro research purposes. They are not intended for human consumption, veterinary application, or any clinical or therapeutic use. All products are sold under a Research Use Only designation and may only be purchased and handled by qualified research professionals aged 21 or older.
The analytical data and purity standards referenced in this article relate to compound characterization for research documentation purposes only. Nothing in this article constitutes a claim regarding suitability for any medical, diagnostic, or therapeutic application. These statements have not been evaluated by the U.S. Food and Drug Administration.
